Gastric adenocarcinoma Clinical Trials
Conditions / Gastric adenocarcinoma
Delta Trials records 230 clinical trials for Gastric adenocarcinoma in its publicly accessible dataset. From the full dataset, 60 actively seeking eligible participants and 67 trials have reached completion. This research is conducted across 766 study locations around the world. An additional 103 trials are active but not currently open for enrollment. Since 2020, 28 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
230
Total Trials
60
Recruiting
67
Completed
103
Other Active
28
Terminated since 2020
766
Study Locations
Browse by location (766 total)
- New York, United States 26 trialsAll trials in New York, United States
- Houston, United States 25 trialsAll trials in Houston, United States
- Beijing, China 25 trialsAll trials in Beijing, China
- Nashville, United States 18 trialsAll trials in Nashville, United States
- Los Angeles, United States 17 trialsAll trials in Los Angeles, United States
- Seoul, South Korea 17 trialsAll trials in Seoul, South Korea
- Boston, United States 16 trialsAll trials in Boston, United States
- Dallas, United States 15 trialsAll trials in Dallas, United States
- Philadelphia, United States 14 trialsAll trials in Philadelphia, United States
- Chicago, United States 14 trialsAll trials in Chicago, United States
- Duarte, United States 14 trialsAll trials in Duarte, United States
- Paris, France 13 trialsAll trials in Paris, France
- Shanghai, China 13 trialsAll trials in Shanghai, China
- Paris, France 13 trialsAll trials in Paris, France
- Milan, Italy 12 trialsAll trials in Milan, Italy
- Barcelona, Spain 12 trialsAll trials in Barcelona, Spain
- San Antonio, United States 12 trialsAll trials in San Antonio, United States
- Guangzhou, China 12 trialsAll trials in Guangzhou, China
- Seattle, United States 12 trialsAll trials in Seattle, United States
- Fuzhou, China 11 trialsAll trials in Fuzhou, China